Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
PRINCETON, N.J. and MORRISVILLE, N.C. – Otsuka Pharmaceutical Development & Commercialization, Inc., and Spencer Health Solutions, Inc today announced an agreement to jointly create a transformational patient experience using the spencer® smart hub, the world’s first at-home medication device that … Learn more